Toggle Main Menu Toggle Search

Open Access padlockePrints

Optimizing risk-reducing surgery and aspirin decision aids for Lynch syndrome carriers using the person-based approach: A think-aloud interview study

Lookup NU author(s): Professor Sir John BurnORCiD

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

© 2025 The Author(s). Journal of Genetic Counseling published by Wiley Periodicals LLC on behalf of National Society of Genetic Counselors.Lynch syndrome “carriers” carry a germline pathogenic variant conferring gene-, sex-, and organ-specific increased cancer risks. They are presented with difficult, interrelated choices over their lifetime. This study was part of a larger project to codesign a health intervention, Lynch Choices™ https://canchoose.org.uk to provide an information hub and decision support for carriers, their family members, and clinicians. This study aimed to answer the research question: What content, framing, and design elements of a decision aid for genetic cancer risk management are important to Lynch syndrome carriers? Adult carriers were invited to a think-aloud interview to hear their thoughts about a prototype version of Lynch Choices™ containing values-clarification exercises. The first half of interviews focused on the gynecological risk-reducing surgery and the second half on the aspirin decision aid. Twenty carriers (eight men) were interviewed, half of whom had a personal history of cancer. Iterative refinement of Lynch Choices™ content and design was completed between interviews using a transparent table of changes from the person-based approach. Following the interviews, reflexive thematic analysis was applied to the entire qualitative dataset. Three themes were constructed to guide further optimization and make recommendations for improved cancer risk communication in clinical practice. The three themes were: (1) Interpreting gene-specific cancer risks and “What does it mean to me?”; (2) Words matter: Careful phrasing is important to feel understood; (3) Decision aids: They can help but might trigger emotions. Think-aloud interviews provided in-depth insight into the psychosocial context of carriers. This informed optimization of the decision aid to support engagement and promote shared decision making with healthcare professionals. The learning from this study had broader implications beyond decision aid development, to understanding preferences, needs, and experiences regarding genetic cancer risk communication and decision support.


Publication metadata

Author(s): Kohut K, Morton K, Turner L, Foster R, Bancroft EK, Burn J, Crosbie EJ, Dominguez-Valentin M, Esplen MJ, Hanson H, Hurley K, Moller P, Ryan N, Snape K, Dale C, Duncombe S, Gold R, Patton S, Rook W, Stephens R, Turner L, Vale F, White H, Woodward I, Worrall S, Young J, Ahmed M, Ambler L, Antoniou A, Archer S, Armstrong R, Bancroft E, Barlow-Stewart K, Barnett L, Bartlett M, Barwell J, Bell D, Berlin C, Blair F, Bradford M, Burn J, Cable S, Cambell-Kelly M, Chauhan D, Cleaver R, Coad B, Connolly G, Crawford G, Crosbie E, Cuthill V, Dabir T, Dominguez-Valentin M, Davies E, Elwyn G, Esplen MJ, Evans DG, Fabricius P, Forman A, Fritzell K, Giffney C, Gomes J, Hall R, Hanson H, Hawkins M, Holliday D, Horgan R, Hurley K, James M, Jewell R, John S, Kiesel V, Koziel A, Kulkarni A, Lalloo F, Liggett H, Limbu A, Lippiett K, Lowry A, Matsukawa M, Manchanda R, Miles T, Milton S, Moller P, Monahan K, Monje-Garcia L, Moslein G, Murray A, Murray J, Ong K-R, Paramasivam A, Pope A, Pugh S, Rafi I, Recchia G, Reents N, Ryan N, Saya S, Sayyed R, Shickh S, Seppala T, Side L, Snape K, Smith S, Smith T, Stacey D, Stayner B, Takamine E, Tatton-Brown K, Petersen HV, Volk R, Westaway K, Warner N, Wiggins J, Wilde L, Williams J, Willis C, Winchester E, Woodward E, Youngs A, Eccles D, Foster C

Publication type: Article

Publication status: Published

Journal: Journal of Genetic Counseling

Year: 2025

Volume: 34

Issue: 4

Print publication date: 01/08/2025

Online publication date: 07/08/2025

Acceptance date: 16/07/2025

Date deposited: 02/09/2025

ISSN (print): 1059-7700

ISSN (electronic): 1573-3599

Publisher: John Wiley and Sons Inc.

URL: https://doi.org/10.1002/jgc4.70089

DOI: 10.1002/jgc4.70089

Data Access Statement: The data that support the findings of this study are available upon request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.

PubMed id: 40772451


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
C61296/A27223
Cancer Research UK. Grant Number: C61296/A27223
National Institute for Health and Care Research (NIHR). Grant Number: NIHR300650
NIHR203308
NIHR203320
NIHR Exeter Biomedical Research Centre. Grant Number: NIHR203320
NIHR Manchester Biomedical Research Centre. Grant Number: NIHR203308
NIHR300650

Share